Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines

BACKGROUND: TAK733 is a novel allosteric, non-ATP-binding, inhibitor of the BRAF substrates MEK-1/2. METHODS: The growth inhibitory effects of TAK733 were assessed in a panel of 27 cutaneous and five uveal melanoma cell lines genotyped for driver oncogenic mutations. Flow cytometry, Western blots an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: von Euw, Erika, Atefi, Mohammad, Attar, Narsis, Chu, Connie, Zachariah, Sybil, Burgess, Barry L, Mok, Stephen, Ng, Charles, Wong, Deborah JL, Chmielowski, Bartosz, Lichter, David I, Koya, Richard C, McCannel, Tara A, Izmailova, Elena, Ribas, Antoni
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2012
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444881/
https://ncbi.nlm.nih.gov/pubmed/22515704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-4598-11-22
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge